Merck & Co., Inc., et al.; FDA Withdraws Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 65 new drug applications and 52 abbreviated new drug applications from multiple pharmaceutical companies, following written notifications from the applicants that the drug products are no longer commercially available.